| Literature DB >> 31739445 |
Mathias Zaunschirm1, Marc Pignitter1, Antonio Kopic1, Claudia Keßler1, Christina Hochkogler1, Nicole Kretschy2, Mark Manuel Somoza2, Veronika Somoza1.
Abstract
The Western diet is characterized by a high consumption of heat-treated fats and oils. During deep-frying processes, vegetable oils are subjected to high temperatures which result in the formation of lipid peroxidation products. Dietary intake of oxidized vegetable oils has been associated with various biological effects, whereas knowledge about the effects of structurally-characterized lipid peroxidation products and their possible absorption into the body is scarce. This study investigates the impact of linoleic acid, one of the most abundant polyunsaturated fatty acids in vegetable oils, and its primary and secondary peroxidation products, 13-HpODE and hexanal, on genomic and metabolomic pathways in human gastric cells (HGT-1) in culture. The genomic and metabolomic approach was preceded by an up-to-six-hour exposure study applying 100 µM of each test compound to the apical compartment in order to quantitate the compounds' recovery at the basolateral side. Exposure of HGT-1 cells to either 100 µM linoleic acid or 100 µM 13-HpODE resulted in the formation of approximately 1 µM of the corresponding hydroxy fatty acid, 13-HODE, in the basolateral compartment, whereas a mean concentration of 0.20 ± 0.13 µM hexanal was quantitated after an equivalent application of 100 µM hexanal. An integrated genomic and metabolomic pathway analysis revealed an impact of the linoleic acid peroxidation products, 13-HpODE and hexanal, primarily on pathways related to amino acid biosynthesis (p < 0.05), indicating that peroxidation of linoleic acid plays an important role in the regulation of intracellular amino acid biosynthesis.Entities:
Keywords: cDNA microarray; gastric cells; hexane; linoleic acid peroxidation products; metabolomics
Mesh:
Substances:
Year: 2019 PMID: 31739445 PMCID: PMC6891525 DOI: 10.3390/molecules24224111
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Quantitation of 13-HODE and hexanal in different compartments (apical, lysate, basolateral) of HGT-1 cells after six-hours incubation with 100 µM linoleic acid and 100 µM 13-HpODE or 0.5 h incubation with 100 µM hexanal a.
| Incubation Substance | Linoleic Acid | 13-HpODE | Hexanal |
|---|---|---|---|
| Quantitation of | 13-HODE [µM] | 13-HODE [µM] | Hexanal [µM] |
|
| 1.11 ± 0.05 a | 1.22 ± 0.05 a | 3.15 ± 0.62 b |
|
| n.d. | n.d. | n.d. |
|
| 1.12 ± 0.05 a | 2.09 ± 0.53 b,* | 0.20 ± 0.13 c,* |
a Data are displayed as mean ± SD (n = 3–4, tr = 1–2). Statistically significant differences were analyzed using two-way ANOVA (p ≤ 0.01), followed by the Holm–Sidak post hoc test (p ≤ 0.05). a,b,c Different letters in a row indicate significant differences between the three treatments (p ≤ 0.05). Asterisks (*) indicate significant differences within one treatment between apical and basolateral compartments (p ≤ 0.05).
Figure 1Scatterplots of log2 fluorescence intensity after six-hours incubation with (A) 100 µM linoleic acid, (B) 100 µM 13-HpODE or (C) 100 µM hexanal in HGT-1 cells. Diagonal represents equal regulation in untreated control and treated samples (n = 3).
Figure 2Scatterplots of metabolomic regulation [log µM] after six-hours incubation with (A) 100 µM linoleic acid, (B) 100 µM 13-HpODE, and (C) 100 µM hexanal in HGT-1 cells. Bisector represents equal regulation in untreated control and treated samples (n = 3–4).
Significantly enriched pathways (p < 0.05) based on the integrated methods pathway analysis after six-hours incubation with 100 µM linoleic acid, 100 µM 13-HpODE, or 100 µM hexanal in HGT-1 cells a.
| Compound | Pathway | Hits (Official Gene Symbol, KEGG Compound Entry) | Topology | |
|---|---|---|---|---|
| Linoleic acid | Pyrimidine metabolism | UMPS, POLR1A, CANT1, NTSC3, TXNRD2, TYMP, TYMS | 0.036 | 0.37 |
| Cyanoamino metabolism | 5HMT1, C00037 | 0.040 | 0.75 | |
| 13-HpODE | Aminoacyl-tRNA biosynthesis | C00123, C00037, RARS2, C00148, FARSB, C00073 | < 0.001 | 0.12 |
| Arginine and proline metabolism | GLS2, ASS1, C00148, GOT2, ALDH3A2 | 0.004 | 0.17 | |
| Linoleic acid metabolism | C00157, PLA2G6, CYP2C8 | 0.006 | 0.88 | |
| Hexanal | Valine, leucine and isoleucine biosynthesis | PDHA1, C00183, C00123 | < 0.001 | 0.45 |
| Aminoacyl-tRNA biosynthesis | C00183, C00123, C00037, C00062, C00073 | < 0.001 | 0.07 | |
| Pantothenate and CoA biosynthesis | VNN2, C00183 | 0.030 | 0.13 | |
| Arginine and proline metabolism | NOS2, C00062, C00077 | 0.044 | 0.27 |
ap-values less than 0.05 indicate a statistical significance compared to non-treated control cells.
Figure 3Integrated pathway analysis of genomic and metabolomic data revealed pathways related to amino acid biosynthesis being influenced by 13-HpODE and hexanal in gastric cells as indicated by thick arrows.